Stock
Recursion Pharmaceuticals In
Ticker not mapped · held by 5 managers
Reported value
$6.42M
Holders
5
+1 new · −0 exited
Holders’ est. mark
−$139.9K
Price effect on 3 books still in the name
Largest holder
$5.89M
BARCLAYS PLC
Holder count by quarter
Who holds it
Notable only| Investor | Shares | Value | Est. mark | Change |
|---|---|---|---|---|
| BARCLAYS PLC | 1.16M | $5.89M | −$135.9K | Added$2.77M |
| Leonteq Securities AG | 65K | $328.9K | −$1.6K | Added$289.7K |
| Cresset Asset Management, LLC | 24.2K | $122.3K | — | Held |
| Sanctuary Advisors, LLC | 15.1K | $76.6K | −$2.41K | Added$21.1K |
| ELEVATION POINT WEALTH PARTNERS, LLC | 77 | $390 | — | New |
Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.